hold on there's just too much going on in Congress lmao...
Prohibits new abortion drug approvals; restricts existing ones.
Sen. Cindy Hyde-Smith (R-MS) and 31 cosponsors.
Introduced in Senate, referred to committee.
This bill, titled the SAVE Moms and Babies Act of 2026, would prevent the Food and Drug Administration (FDA) from approving new abortion medications and cancel certain ongoing research exemptions. For abortion drugs already approved, it would add strict new rules regarding their use and dispensing, including mandatory in-person administration and specific certification for prescribers. Senator Hyde-Smith, a Republican from Mississippi, introduced this bill. It has been sent to the Senate Committee on Health, Education, Labor, and Pensions for review, and no votes have been taken yet.
Introduced Jan 27, 2026
This bill was introduced in the Senate on January 27, 2026, and immediately sent to the Senate Committee on Health, Education, Labor, and Pensions. For the bill to become law, it must first pass through this committee, then be approved by the full Senate, then pass the House of Representatives, and finally be signed by the President. No votes have occurred yet, and it may undergo changes in committee.
If this bill passes, no new abortion drugs would be able to be approved for sale in the U.S., and certain research into these drugs would be stopped. For abortion medications currently on the market, you would no longer be able to get them from a pharmacy or receive them through telehealth; they would have to be administered in person by your prescribing doctor at a clinic, medical office, or hospital. Doctors prescribing these medications would need to complete specific training to be certified, including skills to diagnose ectopic pregnancies and manage complications.
Supporters Say
Supporters argue this bill protects women's health and unborn life by increasing safety regulations and limiting access to abortion drugs.
Critics Say
Critics would likely argue it restricts reproductive healthcare access and interferes with doctor-patient relationships.
The bill's stated purpose, through its full title and definition of 'abortion drug,' indicates a focus on protecting 'unborn child[ren]' and increasing safety for 'expectant moms.' Those in favor would likely emphasize the detailed requirements for medical professionals and the restrictions on dispensing methods as necessary safety measures. Opponents would probably argue that the bill creates unnecessary barriers to accessing reproductive healthcare, potentially delaying care and disproportionately affecting individuals in rural areas or those with limited resources.